NCT01375322View on ClinicalTrials.gov

ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria

PHASE4CompletedINTERVENTIONAL

Enrollment

226

Participants

Timeline

Start Date

June 30, 2007

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions

HypertensionDiabetes Mellitus, Type 2Albuminuria

Interventions

DRUG

Amlodipine+Benazepril

Amlodipine besylate 5 mg + Benazepril hydrochloride 10 mg, daily use and forced titrate till 16-week end

DRUG

Valsartan+Hydrochlorothiazide

Valsartan 80 mg + Hydrochlorothiazide 12.5 mg, daily use and forced titrate till 16-week end

Trial Locations (4)

114

Tri-Service General Hospital, Taipei

220

Far Eastern Memorial Hospital, Taipei

407

Taichung Veterans General Hospital, Taichung

833

Chang Gung Memorial Hospital-Kaohsiung, Kaohsiung City

All Listed Sponsors

lead

TSH Biopharm Corporation Limited

INDUSTRY

NCT01375322 - ADDM Study - Amtrel and Co-Diovan in Type 2 Diabetes Mellitus Hypertension Patients With Microalbuminuria | Biotech Hunter | Biotech Hunter